Imperial Valley News
Washington, DC - On December 16, the United States and Belarus convened the second Working Group for Democracy and Human Rights. Deputy Assistant Secretary for European and Eurasian Affairs Bridget Brink, Deputy Assistant Secretary for Human Rights, Democracy, and Labor Robert Berschinski, and USAID Deputy Assistant Administrator for Europe and Eurasia Jonathan Katz participated for the United States in meetings with senior Belarusian officials, including Foreign Ministry Director for the Americas Oleg Kravchenko and Belarusian Chargé d’Affaires Pavel Shidlovsky.
Washington, DC - The United States is deeply concerned by the recent clashes in the Oromia region of Ethiopia that reportedly have resulted in the deaths of numerous protestors. We greatly regret the deaths that have occurred and express our condolences to the families of those who have lost their lives.
Washington, DC - Joint Statement by Secretary Kerry and Secretary Foxx on the U.S.- Mexico Air Transport Agreement:
FTC Requests Public Comment on Pfizer Inc.’s Application to Modify Final Order Settling Competition Concerns Related to Pfizer’s 2009 Acquisition of Wyeth
Washington, DC - The Federal Trade Commission is seeking public comment on an application by Pfizer Inc. to modify the FTC’s January 2010 final order, which settled the FTC’s competition concerns arising from Pfizer’s 2009 acquisition of Wyeth. The final order remedied the likely anticompetitive effects of the acquisition in numerous markets for animal health products by requiring Pfizer to sell approximately half of Wyeth’s U.S.-based animal health business to Boehringer Ingelheim Vetmedica, Inc. (“BIVI”). It also included additional requirements governing Pfizer’s future conduct.
Washington, DC - Congressman Juan Vargas (CA-51) voted in favor of the $1.15 trillion government spending bill voted on and approved by the House of Representatives today. Over 100 programs supported by Rep. Vargas were included in the bill. Rep. Vargas issued the following statement after voting on the Fiscal Year 2016 Consolidated Appropriations Act:
Washington, DC - Today, the U.S. Food and Drug Administration announced important proposed steps to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults. The FDA is committed to protecting public health by informing consumers of the risks of indoor tanning.